Personalized steroids for severe pneumonia breathing failure
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study tests whether giving a personalized dose of steroids (anti-inflammatory medicine) early can help people with severe pneumonia-related breathing failure recover faster. It compares different steroid doses based on your body's inflammation and immune response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must be in the ICU now or have been admitted within the last 2 days (48 hours).
- You must have been diagnosed with bacterial pneumonia that you caught outside the hospital.
- Your breathing must be severely affected, needing a breathing machine, high-flow oxygen, or a special oxygen mask.
- You must agree to take part and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a corticosteroid (a type of anti-inflammatory medicine) can help people with severe breathing problems or serious infections who have a specific 'hyperinflammatory' pattern. If you are in the ICU on a ventilator, this trial may be an option for you.
This study tests whether a steroid medicine can help adults in the ICU with severe flu pneumonia recover better. If you qualify, you may receive either the steroid or a placebo (dummy treatment) to see if it reduces inflammation and improves breathing.
This trial tests whether adding anti-inflammatory medicine (steroids) to usual care helps people with severe pneumonia recover faster. It only includes patients who are seriously ill in the ICU, and the goal is to find the best way to reduce lung inflammation and improve outcomes.
This trial tests whether giving a steroid (dexamethasone) early to people hospitalized with severe flu pneumonia can improve recovery and reduce the need for breathing support. It may help reduce inflammation in the lungs and lead to better outcomes.
This trial compares two common steroid medicines, hydrocortisone and prednisolone, to see which works better for people with severe community-acquired pneumonia. It aims to find the best treatment to help you recover faster.
This trial tests whether giving steroids (anti-inflammatory medicines) to people with a severe lung infection called Pneumocystis pneumonia (PJP) can improve outcomes. It is for patients who are in the ICU and do not have HIV, which is a different group than typical PJP patients.
Hear when a new Acute Respiratory Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.